MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
about
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasionThe Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell LinesTransactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteinsZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTKDecreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.Clinical significance of E2F1 protein expression in non-small cell lung cancerModulation of cancer traits by tumor suppressor microRNAs.MiR-106a is an independent prognostic marker in patients with glioblastoma.E2F1-miR-20a-5p/20b-5p auto-regulatory feedback loop involved in myoblast proliferation and differentiationPrioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.High-throughput microRNA profiling of pediatric high-grade gliomas.MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.Diagnostic and prognostic value of miR-106a in colorectal cancer.MicroRNAs in neural cell development and brain diseases.Emerging roles of microRNA in modulating cell-death processes in malignant glioma.The miRNA network: micro-regulator of cell signaling in cancer.MicroRNAs and cell cycle of malignant glioma.Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.E2F1: a promising regulator in ovarian carcinoma.Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells.Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.Peri-foci adipose-derived stem cells promote chemoresistance in breast cancerMicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.The miR-106a~363Xpcl1 miRNA cluster induces murine T cell lymphoma despite transcriptional activation of the p27Kip1 cell cycle inhibitor.An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes.CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma.microRNA‑372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1.An ultrasensitive SERS sensor for simultaneous detection of multiple cancer-related miRNAs.mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells.Upregulated miR-106a plays an oncogenic role in pancreatic cancer.MicroRNA-106a inhibits cell proliferation and induces apoptosis in colorectal cancer cells.
P2860
Q24633772-0E98E8F1-8BED-4428-BEBA-038B173FFC60Q28547067-C7866D7E-12F1-4984-837B-26D985965892Q34073992-4A9F6FB1-CB71-47B6-B0C0-D679DDFF955FQ34325808-8FFA0B95-E599-40C6-8719-F66FDA83E680Q34409620-33CF5C95-8C39-40EB-914A-8E368D538F44Q34980918-A1C1955B-05D1-4028-9F5C-891FF0787B1DQ35017237-8FAE7760-7E96-43DA-B6B8-939B50A945F8Q35741033-8AF56C3B-BAA0-448B-B71A-CCA0ADD1F8B3Q35788900-6DB66EFF-E8AD-412F-910A-C13E8FCAEE16Q36245788-7592CF41-E135-4BE3-9BF3-B26AB0CEE214Q36375834-E4DCE43B-19E9-4136-9FC0-3A1139AAA693Q36444495-4C3FEA8B-E517-4AF2-BD43-27F05D75CBD9Q36590130-D2C8974B-A977-4ACB-8D2C-DD8616FCFCE6Q36865988-6792FF22-5095-4C2A-A06C-BD02FF9CECB0Q36990698-EA8C7773-641A-4A92-84A6-2639E130D370Q37335617-78A3CDB0-F4EE-41B4-BF3B-A521AD507194Q37492187-B5D9CAF4-596D-4F11-950A-10BD5A30934DQ37699427-C8E68734-0A8D-40F1-BDB0-B178F2022324Q37706295-21F62DDE-4692-4BE6-94FE-B59875693699Q37974078-0A5D4B56-19F7-4C8A-A4DE-8A046B498E3BQ38127635-B2D1215F-8AB7-4CC5-BCDD-FB67DC774E71Q38243969-0339B92F-2A4E-4259-B7D1-A628B3C9B371Q38497875-5F748E5A-81EB-4C1F-90FB-701E64C39B50Q38621047-83F2BF81-FB17-4CF4-8259-6EE735495EB7Q38691452-C650452C-8989-4C4A-AE2F-6EDFEFB040F9Q38800435-78BA4E4F-1818-4EAD-A92E-8F7AE7CB689AQ39037653-7D9A0310-526B-4BAF-B648-776B4E1FD302Q39096209-3540AAE7-5492-40E7-A3A8-72430DC659E0Q39124132-8FD475B4-7E2B-4A76-8A9A-CEE486FBDA74Q40612887-BC9F0036-429A-42F4-B6FE-0E85046E7D86Q41163628-993F6C3B-6BE9-4D53-B1A8-EFABD0ED3512Q41208796-7DFA1FFC-AF8A-4F67-959F-9B395531A09AQ41612354-63ECD8DE-8C07-4024-9755-56E1313ECFAEQ42013246-73A03655-C5A9-4691-BA50-152F6CD2F8C4Q48400320-C083B139-A7A4-4091-8E10-52CF5EC7185BQ49479439-7ECE38CC-CBAA-44EF-9A1C-EC150C52D931Q51143054-26E05C53-2750-4A4D-8856-BBDC838EA013Q53070197-138C4500-9C39-46D4-B924-B35918E53BF9Q53071807-0692AC33-06DA-4AD2-95FA-2D22566F68E4Q55184609-BBD58022-515F-466A-9FA1-AEA44B783BFC
P2860
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
@en
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
@nl
type
label
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
@en
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
@nl
prefLabel
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
@en
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.
@nl
P2093
P2860
P1476
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status
@en
P2093
Baofeng Yang
Changbin Shi
Guang Yang
Ruyou Zhang
Shiguang Zhao
Xiaofeng Chen
P2860
P2888
P304
P356
10.1007/S00109-011-0775-X
P577
2011-06-09T00:00:00Z